Blue Note Therapeutics raises $26M to help treat cancer-related distress via cognitive behavioral stress management (CBSM)

By SharpBrains | March 9, 2021

Blue Note Ther­a­peu­tics Rais­es $26.25 Mil­lion in Series A Financ­ing (press release): Blue Note Ther­a­peu­tics, Inc., today announced the clos­ing of a Series A financ­ing round of $26.25 mil­lion. Pro­ceeds will allow the com­pa­ny to scale the orga­ni­za­tion and fund near-term clin­i­cal tri­als of its lead pre­scrip­tion dig­i­tal ther­a­peu­tic (PDT), which will poten­tial­ly improve the…

Read More

Growing research aims at helping cancer patients in distress access most-likely-to-help self-care options, from Mindfulness training to Web-based cognitive behavioral therapy (CBT)

By SharpBrains | February 1, 2018

___ Mind­ful­ness in can­cer treat­ment: time to stop and think (The Con­ver­sa­tion): “Breathe deeply and focus on the moment: mind­ful­ness now appears every­where as a tech­nique to improve well-being, includ­ing in health care. Mind­ful­ness train­ing is often sug­gest­ed for can­cer patients to reduce high lev­els of anx­i­ety and dis­tress asso­ci­at­ed with diag­no­sis, treat­ment and anticipation…

Read More

Next: Tools to detect and treat “chemo brain” symptoms common in around 35% of breast cancer survivors

By SharpBrains | March 23, 2015

UCLA study reveals treat­ment for women with breast can­cer suf­fer­ing cog­ni­tive dif­fi­cul­ties (Health­Canal): “UCLA researchers have devel­oped a pro­gram that could improve the day-to-day lives of women with breast can­cer by address­ing post-treat­­ment cog­ni­tive dif­fi­cul­ties, some­times known as “chemo brain,” which can affect up to 35 per­cent of women after their treatments

Read More

Why computerized neuropsychological tests will become routine — chemo brain example

By Alvaro Fernandez | August 4, 2009

Good arti­cle today in the NYT on “chemo brain” — some typ­i­cal short-term and long-term cog­ni­tive con­se­quences of chemother­a­py. The Fog That Fol­lows Chemother­a­py (New York Times) This quote is crit­i­cal — for chemo brain and also for a vari­ety of clin­i­cal con­di­tions that present asso­ci­at­ed cog­ni­tive impair­ments: “Con­trol­ling for brain func­tion before can­cer treat­ment begins…

Read More